Skip to content
INVEST IN THE FUTURE OF OPEN SURGERY

 smart camera instantly shows how blood is flowing through vessels during surgery

Currently, surgical teams have limited options – inject dye or attach ultrasound probe

Options

DYE

Is there flow?

yes

PROBE

How much flow?

70 ml/min

VIEWFLOW

How is it flowing?

←70ml/min3x←70ml/minrecirculating↑ stagnant
Opportunity
Real Problem

1 in 5 heart bypass grafts has insufficient flow

1 in 7 reconstruction tissue flaps dies

The #1 problem surgeons face is knowing if the procedure ends with adequate blood flow.

— Dr. Patel, 19,000 robotics surgeries

Breakthrough

Smart camera – no contact:
Instantly see how blood flows, whenever needed

After seeing this level of information, it would be difficult to operate without it.

— Chief Heart Surgeon, Dr. Theodoro

World-class heart surgeons

Dr. Wolf asked while presenting

Who would want to visualize flow through graft and coronary for obstructive disease—on the table—after cross-clamp—before coming off pump?

A near unanimous response!

21st Century Cardiothoracic Surgical Society | Palm Beach meeting

Repeat their success

Repeat Novadaq’s playbook & performance:

  • Same surgeons, same workflow, but without dye
  • 50%+ sales growth
  • Company valuation of $350M to $792M ($23M to $35M Sales)

Chart Year 2-3, skips 3-year U.S. financial / housing crisis

Executive Leadership

Jim Sund, PhD, MBA – Founder & CEO

 

Proven Path to Market Exit

A multidisciplinary innovator, Jim bridges the gap between quantum-level physics and surgical application. As a NASA Fellow during his doctoral studies at Duke University, Jim completed his PhD in Electrical and Computer Engineering in under three years. He leveraged this time to pioneer foundational computational models for ViewFlow’s proprietary 20-dimensional vision algorithm, solving surface-coverage challenges that previously lacked a viable solution.

By synthesizing a background in Quantum Chemistry and Solid State Physics with the strategic rigor of a Duke MBA, Jim has successfully commercialized health-tech solutions for global leaders like Roche and Merck. Today, he leads ViewFlow Medical in transitioning from deep-tech development to clinical adoption—now collaborating with top-tier institutions including Duke and Rex-UNC to establish a new, non-contact standard of surgical care.

Clinical & Strategic Advisory

Randall Wolf, MD

Cardiothoracic Surgeon Advisor.
Houston Methodist, DeBakey Heart & Vascular.
Inventor of Wolf-mini maze for AFib.

Data‑driven wins

Dennis Robbins, PhD, M.P.H.

Chief Strategy & Payment Advisor.
National Thought Leader.
Author of 11 books.

Could change the Standard of Care

Kimberly Steinmann, MD

Clinical Studies Lead Advisor.
Pediatric Emergency Medicine.
Hematologist and Oncologist.

Relevant to many surgeries

Clinical Collaborations

Engaging with leading academic medical centers to help reduce patient complications and costs and become a future standard of care

Join Series A

What investors are saying

I love knowing my money helps real people recover faster and return to active living.

ViewFlow may well change the standard of care.

Investing in ViewFlow was easy and exciting.

For you, it’s a chance to back something meaningful with real clinical and financial upsides.

$4.5M invested of $5M raise

as cash and IRAs

Back To Top